Original says: tissue source site (TSS) for NCI's clinical proteomic tumor analysis consortium (CPTAC)payment 1-3 at 85%.

Ended Awarded Last action

Contract number
75N91018F00002
Awardee
Awarding agency
Obligated
$231,229

Award facts

Opportunity
  • RFQN02CO5441702 Solicitation number
Contract value 100% obligated
$231,228.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · Tissue source site (TSS) for NCI's clinical proteomic tumor analysis consortium (CPTAC) -$153,790
Exercise an Option P00003 · 1) exercise option period 1; and 2) fund 63 additional cases eligible for payments 1-3 in the amount of $166,540.50 (63 cases X $3,110 per case X 85%). $166,541
Funding Only Action P00002 · To exercise optional quantity 1 to fund 61 cases (payment 2) and 63 cases (payment 3). $86,303
Funding Only Action P00001 · Tissue source site (TSS) for NCI's clinical proteomic tumor analysis consortium (CPTAC)payment 1-3 at 85%. $19,848
Original award $112,328

About this award

This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Biomatrix LLC, a woman-owned, Asian-Pacific American-owned limited liability company, for providing a Tissue Source Site (TSS) in support of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract is a Delivery Order with a Firm Fixed Price valued at $231,228.50. It does not have a set-aside designation and was awarded on September 29, 2018 with a completion date of September 28, 2020. The Tissue Source Site is a key component of the CPTAC program, which conducts large-scale, collaborative proteogenomic studies to accelerate the understanding of cancer biology and improve clinical care.

Quick answers

Who was awarded contract 75N91018F00002?

75N91018F00002 was awarded to Biomatrix LLC by National Cancer Institute (National Institutes of Health) on September 29, 2018.

How much is contract 75N91018F00002 worth?

The government has obligated $231,229 on 75N91018F00002.

Is contract 75N91018F00002 an order under another contract?

Yes. 75N91018F00002 is a delivery order under HHSN261201500046I, an indefinite delivery contract.

Was contract 75N91018F00002 competed?

The extent of competition for 75N91018F00002 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award